Intellectual Property
Our Patents
Austin Biosciences maintains a very strong global intellectual property position in U.S., Japan, EU and other major markets. The patent applications cover the LASSN™ nanotechnology platform and its drug development efforts.
Austin Biosciences has additional patent applications pending that cover LASSN™ drugs that are in its development pipeline. Current coverage extends through 2039 and we are continually inventing and protecting new inventions which will expand and extend coverage beyond 2039.
| No. | Title | Patent Status | Filing Date | |
|---|---|---|---|---|
| 1 | US9993454B2 | Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced Ostwald ripening | Issued | May 15, 2014 |
| 2 | US20190110993A1 | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening | Filed | September 12, 2018 |
| 3 | WO2019055525A1 (World) | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening | Filed | September 12, 2018 |
| 4 | 62/828,292 (US & World) | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening and Immediate Drug Release Following Intravenous Administration | Filed | April 2, 2019 |
| 5 | 62/818,041 (US & World) | Stabilized Solid Nanoparticle Formulations of Cannabinoids and Cannabinoid Analogs with Reduced Ostwald Ripening for Oral, Inhalation, Nasal and Parenteral Drug Delivery | Filed | March 13, 2019 |
| 6 | US2017/0020817A1 | Solid Nanoparticle Formulation Of Microtubule Inhibitors With Reduced Ostwald Ripening For Oral Administration | Filed | December 19, 2014 |
| 7 | JP5571380B2 (Japan Patent) | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances With Reduced Ostwald Ripening | Issued | July 24, 2007 |
| 8 | EP2054036A4 (European Patent) | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances With Reduced Ostwald Ripening | Filed | July 24, 2007 |
| 9 | US8728527B2 | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening | Issued | July 24, 2007 |
